Početna › Steatoza jetre
Kliničke studije za Steatoza jetre koje traže sudionike u SAD-u
65 studija za Steatoza jetre traži sudionike na lokacijama širom Sjedinjenih Američkih Država.
Gradovi s najviše studija
- San Antonio, TX17 studija
- New York City, NY16 studija
- Miami, FL16 studija
- San Diego, CA14 studija
- Austin, TX13 studija
- Houston, TX13 studija
- Richmond, VA12 studija
- Tucson, AZ10 studija
- Chandler, AZ10 studija
- Orlando, FL9 studija
- Hialeah, FL9 studija
- St. Louis, MO9 studija
- Dallas, TX9 studija
- Durham, NC8 studija
- Dayton, OH8 studija
- Little Rock, AR8 studija
- Los Angeles, CA8 studija
- New Orleans, LA8 studija
- Pasadena, CA8 studija
- Ocala, FL8 studija
- Rochester, MN8 studija
- Akron, OH7 studija
- Seattle, WA7 studija
- Washington, DC7 studija
- Parma, OH7 studija
- Lancaster, CA7 studija
- Brownsville, TX7 studija
- Topeka, KS7 studija
- Las Vegas, NV7 studija
- Round Rock, TX7 studija
- Chicago, IL6 studija
- Sugar Land, TX6 studija
- Cape Coral, FL6 studija
- Sarasota, FL6 studija
- Sandy Springs, GA6 studija
- Peoria, AZ6 studija
- Indianapolis, IN6 studija
- Fort Worth, TX6 studija
- Fayetteville, NC6 studija
- Arlington, TX6 studija
Po državama
- Alabama4 studija
- Arizona14 studija
- Arkansas8 studija
- Colorado6 studija
- Connecticut5 studija
- Florida20 studija
- Georgia8 studija
- Illinois6 studija
- Indiana9 studija
- Iowa4 studija
- Kalifornija22 studija
- Kansas7 studija
- Kentucky4 studija
- Louisiana11 studija
- Maryland8 studija
- Massachusetts9 studija
- Michigan8 studija
- Minnesota9 studija
- Mississippi5 studija
- Missouri14 studija
- Nevada7 studija
- New Jersey6 studija
- New Mexico3 studija
- New York17 studija
- North Carolina13 studija
- Ohio15 studija
- Pennsylvania5 studija
- Rhode Island3 studija
- South Carolina5 studija
- Tennessee7 studija
- Texas20 studija
- Utah5 studija
- Virginia14 studija
- Washington7 studija
Nedavno ažurirane studije
Službeni tekst studije (engleski)
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
U tijeku regrutacijaFaza 3
Od 18 do 75 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT07704892A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
U tijeku regrutacijaFaza 3
Od 18 do 75 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT07701993A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 29. ruj 2026. · NCT07527910Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 28. ruj 2026. · NCT05832229Early Tracking of Childhood Health Determinants (ETCHED) Study
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
1 Day – 99 Years · Oba spola · Ažurirano 28. ruj 2026. · NCT03481829A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT05519475A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07165028Impact of Soymilk on Liver Disease Severity of Children With Non-alcoholic Fatty Liver Disease (NAFLD)
U tijeku regrutacijaFaza 2
Od 5 do 16 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT06133101A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
U tijeku regrutacijaFaza 3
Od 18 do 80 godina · Oba spola · Ažurirano 21. ruj 2026. · NCT06528314A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
U tijeku regrutacijaFaza 3
Od 18 do 75 godina · Oba spola · Ažurirano 17. ruj 2026. · NCT07221188Fully Automated High-Throughput Quantitative MRI of the Liver
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 7 godina i više · Oba spola · Ažurirano 16. ruj 2026. · NCT05294471A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 9. ruj 2026. · NCT07288138A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
U tijeku regrutacijaFaza 3
Od 18 do 80 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT06318169A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
U tijeku regrutacijaFaza 3
Od 18 do 75 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT06419374Human Models of Selective Insulin Resistance: Alpelisib, Part I
U tijeku regrutacijaFaza 1Zdravi dobrovoljci dobrodošli
Od 18 do 70 godina · Oba spola · Ažurirano 24. kol 2026. · NCT06354088Quantifying Hepatic Mitochondrial Fluxes in Humans
U tijeku regrutacijaFaza 4
Od 18 do 80 godina · Oba spola · Ažurirano 17. kol 2026. · NCT05305287InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Sve dobne skupine · Oba spola · Ažurirano 17. kol 2026. · NCT05463796Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 25 do 55 godina · Oba spola · Ažurirano 12. kol 2026. · NCT06993454Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
U tijeku regrutacijaFaza 2Zdravi dobrovoljci dobrodošli
Od 18 do 100 godina · Oba spola · Ažurirano 10. kol 2026. · NCT03884075Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 18 do 70 godina · Oba spola · Ažurirano 6. kol 2026. · NCT06335771Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM)
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 18 do 70 godina · Oba spola · Ažurirano 6. kol 2026. · NCT06571474Effects of Peanut Consumption on Adults With Metabolic Associated Fatty Liver Disease
U tijeku regrutacija
Od 30 do 70 godina · Oba spola · Ažurirano 6. kol 2026. · NCT07646197A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
U tijeku regrutacijaFaza 2
Od 18 do 70 godina · Oba spola · Ažurirano 3. kol 2026. · NCT06613698Fibrosis Lessens After Metabolic Surgery
U tijeku regrutacijaFaza 4Zdravi dobrovoljci dobrodošli
Od 18 do 75 godina · Oba spola · Ažurirano 31. srp 2026. · NCT06374875Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)
U tijeku regrutacijaOpažajna studija
Od 12 do 18 godina · Oba spola · Ažurirano 30. srp 2026. · NCT04634643Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.